Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 694
  • Home
  • Print this page
  • Email this page

    Article Cited by others


The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD)

Foroughi Mehdi, Maghsoudi Zahra, Askari Gholamreza

Year : 2016| Volume: 21| Issue : 1 | Page no: 100-104

   This article has been cited by
1 Association of Vitamin D Status With Liver and Kidney Disease: A Systematic Review of Clinical Trials, and Cross-Sectional and Cohort Studies
Seyed Mostafa Parizadeh,Majid Rezayi,Reza Jafarzadeh-Esfehani,Amir Avan,Hamideh Ghazizadeh,Maryam Emadzadeh,Reza Sahebi,Gordon A. Ferns,Majid Ghayour-Mobarhan
International Journal for Vitamin and Nutrition Research. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial
Soraiya Ebrahimpour-Koujan,Amir Ali Sohrabpour,Farshad Foroughi,Ehsan Alvandi,Ahmad Esmaillzadeh
Trials. 2019; 20(1)
[Pubmed]  [Google Scholar] [DOI]
3 The effects of vitamin D treatment on glycemic control, serum lipid profiles, and C-reactive protein in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Alireza Milajerdi,Vahidreza Ostadmohammadi,Sina Amirjani,Fariba Kolahdooz,Zatollah Asemi
International Urology and Nephrology. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
Zeeshan Javed,Maria Papageorgiou,Harshal Deshmukh,Eric Kilpatrick,Vincent Mann,Lynsey Corless,George Abouda,Alan Rigby,Stephen Atkin,Thozhukat Sathyapalan
Nutrients. 2019; 11(1): 188
[Pubmed]  [Google Scholar] [DOI]
5 The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial
Fariba Raygan,Vahidreza Ostadmohammadi,Fereshteh Bahmani,Zatollah Asemi
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2018; 84: 50
[Pubmed]  [Google Scholar] [DOI]
6 Can bone-regulating hormones and nutrients help characterize the metabolically healthy obese phenotype
Deeptha Sukumar,Kendra B Becker,May Cheung,Samantha Diamond,Rittane Duszak,Abeer Aljahdali,Stella L Volpe,Jennifer A Nasser
Nutrition and Health. 2018; 24(3): 153
[Pubmed]  [Google Scholar] [DOI]
7 Vitamin D and Related Deficiencies, Sarcopenia and Visceral Obesity in Obese People with NAFLD
Mihaela Petrova
Gastroenterology & Hepatology: Open Access. 2018; 9(1)
[Pubmed]  [Google Scholar] [DOI]
8 Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle
Eleonora Poggiogalle,Lorenzo Maria Donini,Andrea Lenzi,Claudio Chiesa,Lucia Pacifico
World Journal of Gastroenterology. 2017; 23(10): 1747
[Pubmed]  [Google Scholar] [DOI]
9 Vitamin D supplementation for chronic liver diseases in adults
Goran Bjelakovic,Dimitrinka Nikolova,Marko Bjelakovic,Christian Gluud
Cochrane Database of Systematic Reviews. 2017;
[Pubmed]  [Google Scholar] [DOI]
10 The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
Reza Tabrizi,Mahmood Moosazadeh,Kamran B. Lankarani,Maryam Akbari,Seyed Taghi Heydari,Fariba Kolahdooz,Mansooreh Samimi,Zatollah Asemi
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;
[Pubmed]  [Google Scholar] [DOI]
11 Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
Xi-Xi He,Xiao-Li Wu,Ren-Pin Chen,Chao Chen,Xiao-Gang Liu,Bin-Jiao Wu,Zhi-Ming Huang,Jonathan M Peterson
PLOS ONE. 2016; 11(10): e0162368
[Pubmed]  [Google Scholar] [DOI]
12 Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
Feliciano Chanana Paquissi
Frontiers in Immunology. 2016; 7
[Pubmed]  [Google Scholar] [DOI]


Read this article